Literature DB >> 22778182

Cannabinoid hyperemesis.

Kim Wild1, Hugh Wilson.   

Abstract

A 21-year-old woman presented with a 4-week history of sudden onset vomiting, nausea and anorexia. Questioning revealed that she had a 7-year history of heavy cannabis use (smoking). She did not describe abdominal pain, change in bowel habit, antibiotic use, foreign travel or contact with gastroenteritis. Biochemistry results demonstrated mild metabolic derangement with a low potassium and a low bicarbonate, and urine toxicology was positive for cannabinoids. Other investigations, including a full blood count, renal function tests, liver function tests, a coagulation sample, an ECG, urinary β-hCG and a CT head scan, were all normal. A diagnosis of cannabinoid hyperemesis was made and her symptoms resolved after treatment with intravenous fluids, antiemetics and abstinence from cannabis. Since her discharge and abstinence she has had several relapses, each related to cannabis use and each resolving with abstinence. The patient is now seeking cognitive behavioural therapy to achieve permanent abstinence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22778182      PMCID: PMC3029059          DOI: 10.1136/bcr.01.2010.2605

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study.

Authors:  R W McCallum; I Soykan; K R Sridhar; D A Ricci; R C Lange; M W Plankey
Journal:  Aliment Pharmacol Ther       Date:  1999-01       Impact factor: 8.171

3.  Toxicity with intravenous injection of crude marijuana extract.

Authors:  N D Vaziri; R Thomas; M Sterling; K Seiff; M V Pahl; J Davila; A Wilson
Journal:  Clin Toxicol       Date:  1981-03       Impact factor: 4.467

4.  Cyclic vomiting and compulsive bathing with chronic cannabis abuse.

Authors:  Pavan Chepyala; Kevin W Olden
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

5.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.

Authors:  J H Allen; G M de Moore; R Heddle; J C Twartz
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 6.  Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.

Authors:  F C Machado Rocha; S C Stéfano; R De Cássia Haiek; L M Q Rosa Oliveira; D X Da Silveira
Journal:  Eur J Cancer Care (Engl)       Date:  2008-07-09       Impact factor: 2.520

7.  Cannabinoid hyperemesis: marijuana puts patients in hot water.

Authors:  Duncan Wallace; Ana-Louise Martin; Bianca Park
Journal:  Australas Psychiatry       Date:  2007-04       Impact factor: 1.369

8.  Cannabinoid hyperemesis presenting to a New Zealand hospital.

Authors:  Martin Watts
Journal:  N Z Med J       Date:  2009-02-27

9.  Cannabinoid hyperemesis relieved by compulsive bathing.

Authors:  Yoon Hee Chang; Donna M Windish
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

10.  A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting.

Authors:  Mark A Ware; Paul Daeninck; Vincent Maida
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

View more
  3 in total

1.  Hybrids of chemical derivatives of Escherichia coli alkaline phosphatase.

Authors:  E Meighen; R Yue
Journal:  Biochim Biophys Acta       Date:  1975-12-15

Review 2.  Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2016-12-20

3.  Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.

Authors:  Thangam Venkatesan; David J Levinthal; B U K Li; Sally E Tarbell; Kathleen A Adams; Robert M Issenman; Irene Sarosiek; Safwan S Jaradeh; Ravi N Sharaf; Shahnaz Sultan; Christopher D Stave; Andrew A Monte; William L Hasler
Journal:  Neurogastroenterol Motil       Date:  2019-06       Impact factor: 3.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.